Mustafa Sahbazlar

15PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Environmental studies in animal productionMolecular targetsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 26, 2026
Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

|Oct 23, 2026
Biological frailty and chemotherapy dose intensity independently predict survival in older adults with Stage II-III colon cancer.

|Aug 20, 2026
Prognostic stratification using the Aarhus Composite Biomarker Score in recurrent and metastatic head and neck squamous cell carcinoma.

|Aug 13, 2026
Outcomes and Prognostic Factors of Cetuximab-Based Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

|Jun 11, 2026
Prognostic value of the CHAM score in non-small cell lung cancer patients treated with nivolumab.

|May 27, 2026
A PET-Derived SUVmax-to-Albumin Ratio Predicts Recurrence After Neoadjuvant FLOT in Gastric Cancer.

Pageof 3

Frequent Collaborators

11 joint publications

Ferhat Ekinci

10 joint publications

Atike Pınar Erdogan

3 joint publications

Ahmet Burak Agaoglu

2 joint publications

Tugay Avci